By Erica Teichert ( January 29, 2013, 4:57 PM EST) -- A U.S. Department of Justice official told pharmaceutical companies and counsel on Tuesday that investigating drug misbranding will remain a major priority for the agency in the upcoming year, maintaining that although courts have determined truthful off-label promotion is protected free speech, there is still underlying conduct to prosecute....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.